Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.
J Hepatol
2023
78
4
717-730
Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation.
J Hepatol
2023
79
2
538-551
mRNA 3'UTR lengthening by alternative polyadenylation attenuates inflammatory responses and correlates with virulence of Influenza A virus.
Nat Commun
2023
14
1
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury.
J Hepatol
2023
79
1
150-166
Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes.
Cell Mol Gastroenterol Hepatol
2023
16
2
201-221
Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion.
J Clin Invest
2023
133
21
Correction: A case of novel DYT6 dystonia variant with serious complications after deep brain stimulation therapy: a case report.
BMC Neurol
2022
22
1
A case of novel DYT6 dystonia variant with serious complications after deep brain stimulation therapy: a case report.
BMC Neurol
2022
22
1
METHYLGLYOXAL - A CENTRAL METABOLIC FACTOR IN RESTLESS LEGS SYNDROME?
Sleep Med
2022
100 Suppl 1
S231-S231
Beyond founder and truncting variants in TECPR2-associated disorder
Eur J Hum Genet
2022
30 Suppl 1
SUPPL 1
254-255